Global Wilson's Disease Drugs Market Size, Status and Forecast 2020-2026

May 2020 | 90 pages | ID: GDA932C5C434EN
QYResearch

Abstracts

This report focuses on the global Wilson's Disease Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Wilson's Disease Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Teva Pharmaceutical
• Merck
• Bausch Health
• Mylan
• Tsumura
• Recordati
• Taj Pharmaceutical
• Alexion Pharmaceuticals (Wilson Therapeutics)

Market segment by Type, the product can be split into

• Trientine
• D-penicillamine
• Others

Market segment by Application, split into

• Hospitals
• Clinics
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Wilson's Disease Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Wilson's Disease Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Wilson's Disease Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Wilson's Disease Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Wilson's Disease Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Trientine
  1.4.3 D-penicillamine
  1.4.4 Others
1.5 Market by Application
  1.5.1 Global Wilson's Disease Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinics
  1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Wilson's Disease Drugs Market Perspective (2015-2026)
2.2 Wilson's Disease Drugs Growth Trends by Regions
  2.2.1 Wilson's Disease Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Wilson's Disease Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Wilson's Disease Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Wilson's Disease Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Wilson's Disease Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Wilson's Disease Drugs Players by Market Size
  3.1.1 Global Top Wilson's Disease Drugs Players by Revenue (2015-2020)
  3.1.2 Global Wilson's Disease Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Wilson's Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Wilson's Disease Drugs Market Concentration Ratio
  3.2.1 Global Wilson's Disease Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Wilson's Disease Drugs Revenue in 2019
3.3 Wilson's Disease Drugs Key Players Head office and Area Served
3.4 Key Players Wilson's Disease Drugs Product Solution and Service
3.5 Date of Enter into Wilson's Disease Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Wilson's Disease Drugs Historic Market Size by Type (2015-2020)
4.2 Global Wilson's Disease Drugs Forecasted Market Size by Type (2021-2026)

5 WILSON'S DISEASE DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Wilson's Disease Drugs Market Size by Application (2015-2020)
5.2 Global Wilson's Disease Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Wilson's Disease Drugs Market Size (2015-2020)
6.2 Wilson's Disease Drugs Key Players in North America (2019-2020)
6.3 North America Wilson's Disease Drugs Market Size by Type (2015-2020)
6.4 North America Wilson's Disease Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Wilson's Disease Drugs Market Size (2015-2020)
7.2 Wilson's Disease Drugs Key Players in Europe (2019-2020)
7.3 Europe Wilson's Disease Drugs Market Size by Type (2015-2020)
7.4 Europe Wilson's Disease Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Wilson's Disease Drugs Market Size (2015-2020)
8.2 Wilson's Disease Drugs Key Players in China (2019-2020)
8.3 China Wilson's Disease Drugs Market Size by Type (2015-2020)
8.4 China Wilson's Disease Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Wilson's Disease Drugs Market Size (2015-2020)
9.2 Wilson's Disease Drugs Key Players in Japan (2019-2020)
9.3 Japan Wilson's Disease Drugs Market Size by Type (2015-2020)
9.4 Japan Wilson's Disease Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Wilson's Disease Drugs Market Size (2015-2020)
10.2 Wilson's Disease Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Wilson's Disease Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Wilson's Disease Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Wilson's Disease Drugs Market Size (2015-2020)
11.2 Wilson's Disease Drugs Key Players in India (2019-2020)
11.3 India Wilson's Disease Drugs Market Size by Type (2015-2020)
11.4 India Wilson's Disease Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Wilson's Disease Drugs Market Size (2015-2020)
12.2 Wilson's Disease Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Wilson's Disease Drugs Market Size by Type (2015-2020)
12.4 Central & South America Wilson's Disease Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Teva Pharmaceutical
  13.1.1 Teva Pharmaceutical Company Details
  13.1.2 Teva Pharmaceutical Business Overview and Its Total Revenue
  13.1.3 Teva Pharmaceutical Wilson's Disease Drugs Introduction
  13.1.4 Teva Pharmaceutical Revenue in Wilson's Disease Drugs Business (2015-2020))
  13.1.5 Teva Pharmaceutical Recent Development
13.2 Merck
  13.2.1 Merck Company Details
  13.2.2 Merck Business Overview and Its Total Revenue
  13.2.3 Merck Wilson's Disease Drugs Introduction
  13.2.4 Merck Revenue in Wilson's Disease Drugs Business (2015-2020)
  13.2.5 Merck Recent Development
13.3 Bausch Health
  13.3.1 Bausch Health Company Details
  13.3.2 Bausch Health Business Overview and Its Total Revenue
  13.3.3 Bausch Health Wilson's Disease Drugs Introduction
  13.3.4 Bausch Health Revenue in Wilson's Disease Drugs Business (2015-2020)
  13.3.5 Bausch Health Recent Development
13.4 Mylan
  13.4.1 Mylan Company Details
  13.4.2 Mylan Business Overview and Its Total Revenue
  13.4.3 Mylan Wilson's Disease Drugs Introduction
  13.4.4 Mylan Revenue in Wilson's Disease Drugs Business (2015-2020)
  13.4.5 Mylan Recent Development
13.5 Tsumura
  13.5.1 Tsumura Company Details
  13.5.2 Tsumura Business Overview and Its Total Revenue
  13.5.3 Tsumura Wilson's Disease Drugs Introduction
  13.5.4 Tsumura Revenue in Wilson's Disease Drugs Business (2015-2020)
  13.5.5 Tsumura Recent Development
13.6 Recordati
  13.6.1 Recordati Company Details
  13.6.2 Recordati Business Overview and Its Total Revenue
  13.6.3 Recordati Wilson's Disease Drugs Introduction
  13.6.4 Recordati Revenue in Wilson's Disease Drugs Business (2015-2020)
  13.6.5 Recordati Recent Development
13.7 Taj Pharmaceutical
  13.7.1 Taj Pharmaceutical Company Details
  13.7.2 Taj Pharmaceutical Business Overview and Its Total Revenue
  13.7.3 Taj Pharmaceutical Wilson's Disease Drugs Introduction
  13.7.4 Taj Pharmaceutical Revenue in Wilson's Disease Drugs Business (2015-2020)
  13.7.5 Taj Pharmaceutical Recent Development
13.8 Alexion Pharmaceuticals (Wilson Therapeutics)
  13.8.1 Alexion Pharmaceuticals (Wilson Therapeutics) Company Details
  13.8.2 Alexion Pharmaceuticals (Wilson Therapeutics) Business Overview and Its Total Revenue
  13.8.3 Alexion Pharmaceuticals (Wilson Therapeutics) Wilson's Disease Drugs Introduction
  13.8.4 Alexion Pharmaceuticals (Wilson Therapeutics) Revenue in Wilson's Disease Drugs Business (2015-2020)
  13.8.5 Alexion Pharmaceuticals (Wilson Therapeutics) Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Wilson's Disease Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Wilson's Disease Drugs Revenue
Table 3. Ranking of Global Top Wilson's Disease Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Wilson's Disease Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Trientine
Table 6. Key Players of D-penicillamine
Table 7. Key Players of Others
Table 8. Global Wilson's Disease Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Wilson's Disease Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Wilson's Disease Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Wilson's Disease Drugs Market Share by Regions (2015-2020)
Table 12. Global Wilson's Disease Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Wilson's Disease Drugs Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Wilson's Disease Drugs Market Growth Strategy
Table 18. Main Points Interviewed from Key Wilson's Disease Drugs Players
Table 19. Global Wilson's Disease Drugs Revenue by Players (2015-2020) (Million US$)
Table 20. Global Wilson's Disease Drugs Market Share by Players (2015-2020)
Table 21. Global Top Wilson's Disease Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Wilson's Disease Drugs as of 2019)
Table 22. Global Wilson's Disease Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Wilson's Disease Drugs Product Solution and Service
Table 25. Date of Enter into Wilson's Disease Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Wilson's Disease Drugs Market Size by Type (2015-2020) (Million US$)
Table 28. Global Wilson's Disease Drugs Market Size Share by Type (2015-2020)
Table 29. Global Wilson's Disease Drugs Revenue Market Share by Type (2021-2026)
Table 30. Global Wilson's Disease Drugs Market Size Share by Application (2015-2020)
Table 31. Global Wilson's Disease Drugs Market Size by Application (2015-2020) (Million US$)
Table 32. Global Wilson's Disease Drugs Market Size Share by Application (2021-2026)
Table 33. North America Key Players Wilson's Disease Drugs Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Wilson's Disease Drugs Market Share (2019-2020)
Table 35. North America Wilson's Disease Drugs Market Size by Type (2015-2020) (Million US$)
Table 36. North America Wilson's Disease Drugs Market Share by Type (2015-2020)
Table 37. North America Wilson's Disease Drugs Market Size by Application (2015-2020) (Million US$)
Table 38. North America Wilson's Disease Drugs Market Share by Application (2015-2020)
Table 39. Europe Key Players Wilson's Disease Drugs Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Wilson's Disease Drugs Market Share (2019-2020)
Table 41. Europe Wilson's Disease Drugs Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Wilson's Disease Drugs Market Share by Type (2015-2020)
Table 43. Europe Wilson's Disease Drugs Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Wilson's Disease Drugs Market Share by Application (2015-2020)
Table 45. China Key Players Wilson's Disease Drugs Revenue (2019-2020) (Million US$)
Table 46. China Key Players Wilson's Disease Drugs Market Share (2019-2020)
Table 47. China Wilson's Disease Drugs Market Size by Type (2015-2020) (Million US$)
Table 48. China Wilson's Disease Drugs Market Share by Type (2015-2020)
Table 49. China Wilson's Disease Drugs Market Size by Application (2015-2020) (Million US$)
Table 50. China Wilson's Disease Drugs Market Share by Application (2015-2020)
Table 51. Japan Key Players Wilson's Disease Drugs Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Wilson's Disease Drugs Market Share (2019-2020)
Table 53. Japan Wilson's Disease Drugs Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Wilson's Disease Drugs Market Share by Type (2015-2020)
Table 55. Japan Wilson's Disease Drugs Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Wilson's Disease Drugs Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Wilson's Disease Drugs Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Wilson's Disease Drugs Market Share (2019-2020)
Table 59. Southeast Asia Wilson's Disease Drugs Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Wilson's Disease Drugs Market Share by Type (2015-2020)
Table 61. Southeast Asia Wilson's Disease Drugs Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Wilson's Disease Drugs Market Share by Application (2015-2020)
Table 63. India Key Players Wilson's Disease Drugs Revenue (2019-2020) (Million US$)
Table 64. India Key Players Wilson's Disease Drugs Market Share (2019-2020)
Table 65. India Wilson's Disease Drugs Market Size by Type (2015-2020) (Million US$)
Table 66. India Wilson's Disease Drugs Market Share by Type (2015-2020)
Table 67. India Wilson's Disease Drugs Market Size by Application (2015-2020) (Million US$)
Table 68. India Wilson's Disease Drugs Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Wilson's Disease Drugs Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Wilson's Disease Drugs Market Share (2019-2020)
Table 71. Central & South America Wilson's Disease Drugs Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Wilson's Disease Drugs Market Share by Type (2015-2020)
Table 73. Central & South America Wilson's Disease Drugs Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Wilson's Disease Drugs Market Share by Application (2015-2020)
Table 75. Teva Pharmaceutical Company Details
Table 76. Teva Pharmaceutical Business Overview
Table 77. Teva Pharmaceutical Product
Table 78. Teva Pharmaceutical Revenue in Wilson's Disease Drugs Business (2015-2020) (Million US$)
Table 79. Teva Pharmaceutical Recent Development
Table 80. Merck Company Details
Table 81. Merck Business Overview
Table 82. Merck Product
Table 83. Merck Revenue in Wilson's Disease Drugs Business (2015-2020) (Million US$)
Table 84. Merck Recent Development
Table 85. Bausch Health Company Details
Table 86. Bausch Health Business Overview
Table 87. Bausch Health Product
Table 88. Bausch Health Revenue in Wilson's Disease Drugs Business (2015-2020) (Million US$)
Table 89. Bausch Health Recent Development
Table 90. Mylan Company Details
Table 91. Mylan Business Overview
Table 92. Mylan Product
Table 93. Mylan Revenue in Wilson's Disease Drugs Business (2015-2020) (Million US$)
Table 94. Mylan Recent Development
Table 95. Tsumura Company Details
Table 96. Tsumura Business Overview
Table 97. Tsumura Product
Table 98. Tsumura Revenue in Wilson's Disease Drugs Business (2015-2020) (Million US$)
Table 99. Tsumura Recent Development
Table 100. Recordati Company Details
Table 101. Recordati Business Overview
Table 102. Recordati Product
Table 103. Recordati Revenue in Wilson's Disease Drugs Business (2015-2020) (Million US$)
Table 104. Recordati Recent Development
Table 105. Taj Pharmaceutical Company Details
Table 106. Taj Pharmaceutical Business Overview
Table 107. Taj Pharmaceutical Product
Table 108. Taj Pharmaceutical Revenue in Wilson's Disease Drugs Business (2015-2020) (Million US$)
Table 109. Taj Pharmaceutical Recent Development
Table 110. Alexion Pharmaceuticals (Wilson Therapeutics) Business Overview
Table 111. Alexion Pharmaceuticals (Wilson Therapeutics) Product
Table 112. Alexion Pharmaceuticals (Wilson Therapeutics) Company Details
Table 113. Alexion Pharmaceuticals (Wilson Therapeutics) Revenue in Wilson's Disease Drugs Business (2015-2020) (Million US$)
Table 114. Alexion Pharmaceuticals (Wilson Therapeutics) Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Wilson's Disease Drugs Market Share by Type: 2020 VS 2026
Figure 2. Trientine Features
Figure 3. D-penicillamine Features
Figure 4. Others Features
Figure 5. Global Wilson's Disease Drugs Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Wilson's Disease Drugs Report Years Considered
Figure 10. Global Wilson's Disease Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Wilson's Disease Drugs Market Share by Regions: 2020 VS 2026
Figure 12. Global Wilson's Disease Drugs Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Wilson's Disease Drugs Market Share by Players in 2019
Figure 15. Global Top Wilson's Disease Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Wilson's Disease Drugs as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Wilson's Disease Drugs Revenue in 2019
Figure 17. North America Wilson's Disease Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Wilson's Disease Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Wilson's Disease Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Wilson's Disease Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Wilson's Disease Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Wilson's Disease Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Wilson's Disease Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Teva Pharmaceutical Revenue Growth Rate in Wilson's Disease Drugs Business (2015-2020)
Figure 26. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Merck Revenue Growth Rate in Wilson's Disease Drugs Business (2015-2020)
Figure 28. Bausch Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Bausch Health Revenue Growth Rate in Wilson's Disease Drugs Business (2015-2020)
Figure 30. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Mylan Revenue Growth Rate in Wilson's Disease Drugs Business (2015-2020)
Figure 32. Tsumura Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Tsumura Revenue Growth Rate in Wilson's Disease Drugs Business (2015-2020)
Figure 34. Recordati Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Recordati Revenue Growth Rate in Wilson's Disease Drugs Business (2015-2020)
Figure 36. Taj Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Taj Pharmaceutical Revenue Growth Rate in Wilson's Disease Drugs Business (2015-2020)
Figure 38. Alexion Pharmaceuticals (Wilson Therapeutics) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Alexion Pharmaceuticals (Wilson Therapeutics) Revenue Growth Rate in Wilson's Disease Drugs Business (2015-2020)
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed